286 related articles for article (PubMed ID: 16231730)
1. [Altered expression of myostatin gene in the progressive muscular dystrophy patients].
Zhang Y; Chen Y; Chen JW; Zhu DH
Yi Chuan Xue Bao; 2005 Aug; 32(8):779-83. PubMed ID: 16231730
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection.
Shao C; Liu M; Wu X; Ding F
Microsurgery; 2007; 27(5):487-93. PubMed ID: 17596894
[TBL] [Abstract][Full Text] [Related]
3. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
4. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.
Sharma M; Kambadur R; Matthews KG; Somers WG; Devlin GP; Conaglen JV; Fowke PJ; Bass JJ
J Cell Physiol; 1999 Jul; 180(1):1-9. PubMed ID: 10362012
[TBL] [Abstract][Full Text] [Related]
5. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.
Bogdanovich S; McNally EM; Khurana TS
Muscle Nerve; 2008 Mar; 37(3):308-16. PubMed ID: 18041051
[TBL] [Abstract][Full Text] [Related]
6. Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
Castro-Gago M; Blanco-Barca MO; Eiris-Puñal J; Carneiro I; Arce VM; Devesa J
Pediatr Neurol; 2006 Apr; 34(4):281-4. PubMed ID: 16638502
[TBL] [Abstract][Full Text] [Related]
7. Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies.
Hadj Salem I; Kamoun F; Louhichi N; Rouis S; Mziou M; Fendri-Kriaa N; Makni-Ayadi F; Triki C; Fakhfakh F
Biosci Rep; 2011 Apr; 31(2):125-35. PubMed ID: 20477750
[TBL] [Abstract][Full Text] [Related]
8. cDNA encoding sequences for myostatin and FGF6 in sea bass (Dicentrarchus labrax, L.) and the effect of fasting and refeeding on their abundance levels.
Terova G; Bernardini G; Binelli G; Gornati R; Saroglia M
Domest Anim Endocrinol; 2006 May; 30(4):304-19. PubMed ID: 16183242
[TBL] [Abstract][Full Text] [Related]
9. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.
Hermanová M; Zapletalová E; Sedlácková J; Chrobáková T; Letocha O; Kroupová I; Zámecník J; Vondrácek P; Mazanec R; Maríková T; Vohánka S; Fajkusová L
Muscle Nerve; 2006 Mar; 33(3):424-32. PubMed ID: 16372320
[TBL] [Abstract][Full Text] [Related]
10. Transgenic salmon overexpressing growth hormone exhibit decreased myostatin transcript and protein expression.
Roberts SB; McCauley LA; Devlin RH; Goetz FW
J Exp Biol; 2004 Oct; 207(Pt 21):3741-8. PubMed ID: 15371481
[TBL] [Abstract][Full Text] [Related]
11. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells.
Artaza JN; Bhasin S; Mallidis C; Taylor W; Ma K; Gonzalez-Cadavid NF
J Cell Physiol; 2002 Feb; 190(2):170-9. PubMed ID: 11807821
[TBL] [Abstract][Full Text] [Related]
12. Expression of alternatively spliced transcripts for a myostatin-like protein in the blackback land crab, Gecarcinus lateralis.
Covi JA; Kim HW; Mykles DL
Comp Biochem Physiol A Mol Integr Physiol; 2008 Aug; 150(4):423-30. PubMed ID: 18547854
[TBL] [Abstract][Full Text] [Related]
13. Temporal and spatial expression of the myostatin gene during chicken embryo development.
Castelhano-Barbosa EC; Gabriel JE; Alvares LE; Monteiro-Vitorello CB; Coutinho LL
Growth Dev Aging; 2005; 69(1):3-12. PubMed ID: 16180589
[TBL] [Abstract][Full Text] [Related]
14. Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice.
Miyake M; Hayashi S; Sato T; Taketa Y; Watanabe K; Hayashi S; Tanaka S; Ohwada S; Aso H; Yamaguchi T
Cell Biol Int; 2007 Oct; 31(10):1274-9. PubMed ID: 17590360
[TBL] [Abstract][Full Text] [Related]
15. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
16. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
[TBL] [Abstract][Full Text] [Related]
17. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy.
Chen YW; Nagaraju K; Bakay M; McIntyre O; Rawat R; Shi R; Hoffman EP
Neurology; 2005 Sep; 65(6):826-34. PubMed ID: 16093456
[TBL] [Abstract][Full Text] [Related]
18. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
[TBL] [Abstract][Full Text] [Related]
19. Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida K
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
[TBL] [Abstract][Full Text] [Related]
20. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
